Scarica l'app Stockscreener
54.29
1.25%
0.67
Dopo l'orario di chiusura:
54.00
-0.29
-0.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance
Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeat
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia
After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView
TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView
NKB2 Forecast — Price Target — Prediction for 2027 - TradingView
Investigation launched into TG Therapeutics' of... - Pluang
Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar
TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch - Stocktwits
TG Therapeutics, Inc. (TGTX) Options ChainYahoo Finance - ca.finance.yahoo.com
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc (TGTX) Stock Price Today: $56.12 - Pluang
(TGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Latest Stock News & Headlines - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill
TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - Benzinga
TGTX 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys Before Sept. 16th Deadline in Securities Fraud Class Action - TMX Newsfile
TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView
TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance
TG Therapeutics (TGTX) Stock May Be Undervalued On Its Earnings Story - Simply Wall Street
Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock - Benzinga
Tax-related share sale by TG Therapeutics (TGTX) director - stocktitan.net
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem With A 29% Upside Potential - DirectorsTalk Interviews
TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - 富途牛牛
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TGTX Stock On Track For Best Day In 3.5 Months Amid Fresh Buyout Rumors - Stocktwits
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan
TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada
TGTX: BRIUMVI targets $1B+ run rate, expanding with subQ and simplified dosing, backed by strong IP - TradingView
TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth - Eastern Progress
TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
TG Therapeutics to Participate in the Cantor Global Healthcare Conference - manilatimes.net
B. Riley Securities Remains a Buy on TG Therapeutics (TGTX) - The Globe and Mail
(TGTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily
TG Therapeutics (TGTX) Up 15.1% Since Last Earnings Report: Can It Continue? - finance.yahoo.com
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86 - Moomoo
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):